Trials / Completed
CompletedNCT01941472
Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Fluid challenge is often carried out in critical ill patients. Its responsiveness usually requires invasive monitoring. To use non-invasive methods is very tempting. Investigators hypothesize that transcutaneous pO2,transcutaneous pCO2 and Central Venous SO2 variations provide feasible estimation on fluid responsiveness in critical ill patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | fluid challenge | A bag of 500ml of normal saline or 4% gelatin (Gelofusine, B. Braun Medical (Suzhou) Company Limited, Suzhou, China) is infused within 15 minutes using a bag pressurized to 300 mmHg. All other treatments, including maintenance fluids, dose of vasoactive agents and ventilator settings, remain unchanged during the study period. |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2013-09-13
- Last updated
- 2017-04-04
- Results posted
- 2017-03-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01941472. Inclusion in this directory is not an endorsement.